# A Study of How the Body Absorbs LY3537031

> **NCT07202871** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 46 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3537031
- **DRUG:** LY3537031

## Key facts

- **NCT ID:** NCT07202871
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07202871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07202871, "A Study of How the Body Absorbs LY3537031". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07202871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*